Company intelligence / Profile preview

Entirety Biomedical

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Entirety Therapeutics is a biotechnology company dedicated to advancing precision immunology through the interrogation of spatial biology. By mapping the complex interactions within the immune system at a high resolution, the company aims to discover and develop novel therapies for chronic inflammatory and autoimmune conditions. Incubated by ARCH Venture Partners, Entirety leverages its proprietary platform to identify disease-driving pathways that are often missed by traditional bulk analysis methods. The company is currently in the pre-clinical stage, focusing on translating its spatial insights into a pipeline of targeted therapeutic candidates.

Therapeutic areas: Immunology
Modalities: Small moleculeMonoclonal antibody
Industry: Biotech

Beyond the preview

Go deeper on Entirety Biomedical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Entirety Biomedical.

Explore the full profile